Home › Funds › Calamos Advisors LLC › MRK

Calamos Advisors LLC position in MRK

MERCK & CO · Health Care

Calamos Advisors LLC reported holding 799,616 shares of MRK (MERCK & CO) in its Q3 2026 13F filing — a position valued at US$116.2M, representing 0.62% of its reported portfolio and ranking #32 among its reported holdings. Calamos Advisors LLC has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)799.62K sh
Reported value held$116.19M
Portfolio Weight0.62%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Calamos Advisors LLC's MRK position evolved

Calamos Advisors LLC first disclosed a stake in MRK in Q3 2023 at 30,500 shares (US$3.5M). The position peaked in Q3 2026 at 799,616 shares, worth US$116.2M. Across 13 filings, Calamos Advisors LLC increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 799,616 shares valued at US$116.2M — an increase of 149,113 shares quarter over quarter.. Notable position changes include a 2986% increase in Q4 2023 (shares rose 22% over the following quarter), a 1235% increase in Q2 2024 (shares fell 8% over the following quarter), a 1144% increase in Q3 2025 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 30.50K $3.52M New
Q4 2023 941.27K $102.62M Add
Q1 2024 70.00K $7.63M Reduce
Q2 2024 934.41K $115.68M Add
Q3 2024 953.70K $108.30M Add
Q4 2024 852.85K $84.84M Reduce
Q1 2025 668.22K $59.98M Reduce
Q2 2025 41.00K $3.68M Reduce
Q3 2025 510.20K $42.82M Add
Q4 2025 60.00K $5.04M Reduce
Q1 2026 54.00K $5.68M Reduce
Q2 2026 650.50K $83.59M Add
Q3 2026 799.62K $116.19M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRK and 13F data

MRK (MERCK & CO) is a Health Care company. 30 other funds we track also report a position in MRK — the largest reported positions include BlackRock Inc (US$29.17B), Vanguard Group (US$26.77B), VANGUARD CAPITAL MANAGEMENT LLC (US$23.47B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRK

All MRK fund holders →

FAQ

How long has Calamos Advisors LLC held MRK?

Calamos Advisors LLC has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Calamos Advisors LLC's current position in MRK?

As of Q3 2026, Calamos Advisors LLC holds 799.62K shares of MRK (MERCK & CO), valued at $116.19M, representing 0.62% of its reported portfolio and ranking #32.

Has Calamos Advisors LLC been buying or selling MRK?

In the latest 13F filing (Q3 2026), Calamos Advisors LLC increased its position in MRK. The position peaked in Q3 2026 at 799.62K shares.

Which other funds hold MRK?

Other major institutional holders of MRK include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.